EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and characterization of a thermo-responsive, CT-detectable, biocompatible fiducial marker for potential application in image-guided radiotherapy

Saeideh Arsalani, Alireza Zomorodian, Mina Maksimos, Saad Asim, Tithi Bhattacharyya, Yun-Cheng Liu, Obed Asare, Feda Azab, Anne M Alsup, Muhammad Rizwan, Emina Huang, Abdel Kareem Azab

Biomaterials and Biosystems · 2026-12 · 24 · 100153

DOI: 10.1016/j.bbiosy.2026.100153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials and Biosystems, 2026-12. Verfasst von Saeideh Arsalani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, TX, USA. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health National Cancer Institute, Cancer Prevention and Research Institute of Texas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy remains underutilized in colon cancer despite the intrinsic radiosensitivity of colon cancer cells, largely because accurate targeting of tumors within the highly mobile colon is technically challenging. Tumor motion caused by peristalsis, bowel motility, and respiration limits the precision of radiation delivery and increases the risk of damage to surrounding radiosensitive tissues. Current endoscopic tattooing agents used for tumor localization are used for operative localization only and lack radiographic visibility, may diffuse from the injection site, and can induce local inflammation. Here, we developed a thermo-responsive, CT-detectable, injectable fiducial marker composed of Poly(N-isopropylacrylamide) (PNIPAM) loaded with barium sulfate (BaSO₄) for potential application in tumor localization during image-guided radiotherapy. The PNIPAM-BaSO₄ formulation remained injectable at room temperature and rapidly underwent in situ gelation within approximately 15 s at physiological temperature. Micro-CT imaging demonstrated strong dose-dependent radiopacity both in vitro and in vivo, supporting the potential of the marker for CT-based visualization. The marker exhibited stable mass retention for up to 280 days in vitro, and maintained stable localization and radiographic signal for 3 months in vivo without detectable diffusion. Histopathological analysis revealed no evidence of local inflammation, fibrosis, necrosis, or systemic toxicity, demonstrating excellent biocompatibility. Collectively, these findings establish the feasibility of the PNIPAM-BaSO₄ platform as a stable, CT-detectable fiducial marker and support its further development for potential application in image-guided radiotherapy. Future studies will evaluate its performance under clinically relevant radiotherapy imaging and treatment conditions, including its potential use for interfractional localization of mobile tumors.

Schlagwörter

Stichwörter der Autor:innen

Barium sulfateCT markerColorectal cancerImage-guided radiation therapyPNIPAMTumor localization

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Förderung

  • NCI NIH HHS
  • National Institutes of Health National Cancer Institute
  • Cancer Prevention and Research Institute of Texas

Zitieren

APA

Arsalani, S., Zomorodian, A., Maksimos, M., Asim, S., Bhattacharyya, T., Liu, Y. C., Asare, O., Azab, F., Alsup, A. M., Rizwan, M., Huang, E., & Azab, A. K. (2026). Development and characterization of a thermo-responsive, CT-detectable, biocompatible fiducial marker for potential application in image-guided radiotherapy. Biomaterials and Biosystems, 24, 100153. https://doi.org/10.1016/j.bbiosy.2026.100153

Vancouver

Arsalani S, Zomorodian A, Maksimos M, Asim S, Bhattacharyya T, Liu YC, et al. Development and characterization of a thermo-responsive, CT-detectable, biocompatible fiducial marker for potential application in image-guided radiotherapy. Biomaterials and Biosystems. 2026;24:100153. doi:10.1016/j.bbiosy.2026.100153

BibTeX
@article{Arsalani2026,
  author = {Arsalani, Saeideh and Zomorodian, Alireza and Maksimos, Mina and Asim, Saad and Bhattacharyya, Tithi and Liu, Yun-Cheng and Asare, Obed and Azab, Feda and Alsup, Anne M and Rizwan, Muhammad and Huang, Emina and Azab, Abdel Kareem},
  title = {Development and characterization of a thermo-responsive, CT-detectable, biocompatible fiducial marker for potential application in image-guided radiotherapy},
  journal = {Biomaterials and Biosystems},
  year = {2026},
  volume = {24},
  pages = {100153},
  doi = {10.1016/j.bbiosy.2026.100153}
}
Kostenlos starten →